<DOC>
	<DOCNO>NCT02538107</DOCNO>
	<brief_summary>This observational study investigate efficacy safety methoxy polyethyleneglycol-epoetin beta participant kidney transplant . Data participant collect 15 month Mircera therapy .</brief_summary>
	<brief_title>An Observational Study Methoxy Polyethylene Glycol-epoetin Beta Participants With Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Participants kidney transplant chronic kidney disease ( CKD ) , need erythropoiesis stimulating agent ( ESA ) therapy part medical care prescribe methoxy polyethyleneglycolepoetin beta doctor . The transplant function regularly without need continuous dialysis treatment inclusion also documentation period study accord treat physician 's prognosis . Kidney transplantation date back less 3 month . Acute decrease hemoglobin ( Hb ) enrollment , define decrease great equal ( &gt; /= ) 2 g/dL two sequential value . Administration ESA therapies observation period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>